Class information for:
Level 2: XRCC1//GEMCITABINE//ERCC1

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1422 7962 35.8 81%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
216 3       NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG 51214
1422 2             XRCC1//GEMCITABINE//ERCC1 7962
683 1                   NON SMALL CELL LUNG CANCER//VINORELBINE//GEMCITABINE 3165
2272 1                   XRCC1//XRCC3//XPD 2300
8385 1                   GEMCITABINE//DEOXYCYTIDINE KINASE//HENT1 1259
13007 1                   ERCC1//RRM1//MED OVARIAN CANC SECT 866
22701 1                   PEMETREXED//MULTITARGETED ANTIFOLATE//AFFILIATED JIANGSU CANC HOSP 372

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 XRCC1 authKW 1061812 5% 77% 362
2 GEMCITABINE authKW 946290 12% 25% 986
3 ERCC1 authKW 842115 4% 70% 312
4 NON SMALL CELL LUNG CANCER authKW 677194 16% 14% 1308
5 PEMETREXED authKW 522425 4% 42% 327
6 XRCC3 authKW 425369 2% 84% 132
7 XPD authKW 290651 2% 59% 128
8 VINORELBINE authKW 228695 3% 25% 237
9 ERCC2 authKW 207355 1% 78% 69
10 LUNG CANCER journal 201871 6% 11% 483

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 142838 68% 1% 5435
2 Respiratory System 12608 11% 0% 862
3 Pharmacology & Pharmacy 1658 11% 0% 869
4 Genetics & Heredity 1270 7% 0% 530
5 Toxicology 440 3% 0% 241
6 Medicine, Research & Experimental 211 3% 0% 252
7 Hematology 100 2% 0% 155
8 Pathology 66 2% 0% 124
9 Biotechnology & Applied Microbiology 60 3% 0% 221
10 Public, Environmental & Occupational Health 31 2% 0% 185

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MED ONCOL 72398 12% 2% 942
2 AFFILIATED JIANGSU CANC HOSP 53999 0% 41% 34
3 MED OVARIAN CANC SECT 45387 0% 79% 15
4 TERRY FOX CANC 45040 1% 29% 40
5 THORAC ONCOL 44582 2% 8% 156
6 CATHEDRAL MOTHERS CHILDS HLTH 34845 0% 91% 10
7 THORAC ONCOL UNIT 26835 0% 22% 32
8 THORAC ONCOL PROGRAM 26680 0% 18% 39
9 CHEMOTHER Y 25515 1% 7% 90
10 CLIN GYNAECOL SURG 23477 0% 88% 7

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 LUNG CANCER 201871 6% 11% 483
2 SEMINARS IN ONCOLOGY 74164 4% 6% 318
3 JOURNAL OF THORACIC ONCOLOGY 43141 2% 7% 174
4 CLINICAL LUNG CANCER 38954 1% 12% 88
5 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 28450 3% 4% 205
6 CANCER CHEMOTHERAPY AND PHARMACOLOGY 25212 3% 3% 221
7 ANNALS OF ONCOLOGY 24140 3% 3% 229
8 TUMOR BIOLOGY 13808 2% 2% 150
9 JOURNAL OF CLINICAL ONCOLOGY 13744 3% 2% 244
10 CANCER TREATMENT REPORTS 10182 1% 4% 77

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 XRCC1 1061812 5% 77% 362 Search XRCC1 Search XRCC1
2 GEMCITABINE 946290 12% 25% 986 Search GEMCITABINE Search GEMCITABINE
3 ERCC1 842115 4% 70% 312 Search ERCC1 Search ERCC1
4 NON SMALL CELL LUNG CANCER 677194 16% 14% 1308 Search NON+SMALL+CELL+LUNG+CANCER Search NON+SMALL+CELL+LUNG+CANCER
5 PEMETREXED 522425 4% 42% 327 Search PEMETREXED Search PEMETREXED
6 XRCC3 425369 2% 84% 132 Search XRCC3 Search XRCC3
7 XPD 290651 2% 59% 128 Search XPD Search XPD
8 VINORELBINE 228695 3% 25% 237 Search VINORELBINE Search VINORELBINE
9 ERCC2 207355 1% 78% 69 Search ERCC2 Search ERCC2
10 DNA REPAIR GENES 182147 1% 49% 98 Search DNA+REPAIR+GENES Search DNA+REPAIR+GENES

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 FENG, YZ , LIU, YL , HE, XF , WEI, W , SHEN, XL , XIE, DL , (2014) ASSOCIATION BETWEEN THE XRCC1 ARG194TRP POLYMORPHISM AND RISK OF CANCER: EVIDENCE FROM 201 CASE-CONTROL STUDIES.TUMOR BIOLOGY. VOL. 35. ISSUE 11. P. 10677 -10697 183 92% 6
2 STEWART, DJ , CHIRITESCU, G , DAHROUGE, S , BANERJEE, S , TOMIAK, EM , (2007) CHEMOTHERAPY DOSE - RESPONSE RELATIONSHIPS IN NON-SMALL CELL LUNG CANCER AND IMPLIED RESISTANCE MECHANISMS.CANCER TREATMENT REVIEWS. VOL. 33. ISSUE 2. P. 101-137 222 81% 12
3 HE, XF , WEI, W , LI, JL , SHEN, XL , DING, DP , WANG, SL , LIU, ZZ , QIN, JB , WU, LX , XIE, DL , (2013) ASSOCIATION BETWEEN THE XRCC3 T241M POLYMORPHISM AND RISK OF CANCER: EVIDENCE FROM 157 CASE-CONTROL STUDIES.GENE. VOL. 523. ISSUE 1. P. 10 -19 133 90% 17
4 ELNAGGAR, M , GIOVANNETTI, E , PETERS, GJ , (2012) MOLECULAR TARGETS OF GEMCITABINE ACTION: RATIONALE FOR DEVELOPMENT OF NOVEL DRUGS AND DRUG COMBINATIONS.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 19. P. 2811-2829 159 73% 13
5 SCULIER, JP , MORO-SIBILOT, D , (2009) FIRST- AND SECOND-LINE THERAPY FOR ADVANCED NONSMALL CELL LUNG CANCER.EUROPEAN RESPIRATORY JOURNAL. VOL. 33. ISSUE 4. P. 915-930 129 91% 29
6 MACERELLI, M , GANZINELLI, M , GOUEDARD, C , BROGGINI, M , GARASSINO, MC , LINARDOU, H , DAMIA, G , WIESMULLER, L , (2016) CAN THE RESPONSE TO A PLATINUM-BASED THERAPY BE PREDICTED BY THE DNA REPAIR STATUS IN NON-SMALL CELL LUNG CANCER?.CANCER TREATMENT REVIEWS. VOL. 48. ISSUE . P. 8 -19 105 67% 2
7 KOBERLE, B , KOCH, B , FISCHER, BM , HARTWIG, A , (2016) SINGLE NUCLEOTIDE POLYMORPHISMS IN DNA REPAIR GENES AND PUTATIVE CANCER RISK.ARCHIVES OF TOXICOLOGY. VOL. 90. ISSUE 10. P. 2369 -2388 127 61% 0
8 ZHOU, PT , LI, B , JI, J , WANG, MM , GAO, CF , (2015) A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE ASSOCIATION BETWEEN OGG1 SER326CYS POLYMORPHISM AND CANCERS.MEDICAL ONCOLOGY. VOL. 32. ISSUE 2. P. - 94 82% 0
9 CICCOLINI, J , SERDJEBI, C , PETERS, GJ , GIOVANNETTI, E , (2016) PHARMACOKINETICS AND PHARMACOGENETICS OF GEMCITABINE AS A MAINSTAY IN ADULT AND PEDIATRIC ONCOLOGY: AN EORTC-PAMM PERSPECTIVE.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 78. ISSUE 1. P. 1 -12 81 80% 2
10 WEI, BB , ZHOU, Y , XU, ZQ , XI, B , CHENG, H , RUAN, J , ZHU, M , HU, Q , WANG, Q , WANG, ZR , ET AL (2011) THE EFFECT OF HOGG1 SER326CYS POLYMORPHISM ON CANCER RISK: EVIDENCE FROM A META-ANALYSIS.PLOS ONE. VOL. 6. ISSUE 11. P. - 89 86% 16

Classes with closest relation at Level 2


Rank Class id link
1 1717 GEFITINIB//EGFR MUTATION//MIDKINE
2 1102 PACLITAXEL//TAXANES//EPOTHILONES
3 337 THORAC SURG//LUNG CANCER//RESPIRATORY SYSTEM
4 1593 XERODERMA PIGMENTOSUM//COCKAYNE SYNDROME//NUCLEOTIDE EXCISION REPAIR
5 1176 THYMIDYLATE SYNTHASE//THYMIDINE PHOSPHORYLASE//5 FLUOROURACIL
6 1612 SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE
7 2341 RIBONUCLEOTIDE REDUCTASE//POLG//HYDROXYUREA
8 1228 BASE EXCISION REPAIR//DNA GLYCOSYLASE//OXIDATIVE DNA DAMAGE
9 1741 GSTM1//GSTT1//GLUTATHIONE S TRANSFERASE
10 1065 CISPLATIN//NEPHROTOXICITY//PLATINUMII COMPLEXES

Go to start page